Loading organizations...
Key people at 325 Capital.
325 Capital operates as an investment management firm, building value via strategic investments in high-quality, small-cap companies. It constructs concentrated portfolios, taking significant minority shareholder positions and employing a data-driven, analytical methodology. The firm provides investment advisory, asset management, and financial services, aiming for capital preservation and growth for its portfolio.
Anil Shrivastava, a Founder and Managing Partner, leads 325 Capital. He brings over 16 years of direct company investment experience, including service on numerous private company boards. The firm's leadership collectively leverages decades of expertise in private equity and management consulting, notably from institutions like Bain & Co., underpinning their collaborative investment approach.
325 Capital primarily serves the management teams and boards of its small-cap portfolio companies. Its vision is to be a constructive partner, fostering transparency, alignment, and fact-based collaboration. The firm strives to create enduring value and support strategic development, guiding companies towards sustained long-term success.
Key people at 325 Capital.
| Date | Company | Round | Lead Investor(s) | Co-Investor(s) |
|---|---|---|---|---|
| Jan 9, 2023 | Lifecore Biomedical | $38.8M Series A | 22NW Fund, Legion Partners | Cove Street Partners, Wynnefield Capital |